GO:0045906 negative regulation of vasoconstriction: Vascular Tone Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045906 (negative regulation of vasoconstriction) describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of vasoconstriction, the narrowing of blood vessels [1,7].
• It is a biological_process ontology term that operates through ion channels, signaling molecules, and structural proteins in vascular smooth muscle and endothelial cells [3,4,7,8].
• Key molecular players include potassium channels such as Kv7 channels, calcium-sensing receptors, and caldesmon, which modulate vascular smooth muscle contractility [2,3,4].
• Dysregulation of this process contributes to neurogenic orthostatic hypotension, vascular calcification, and cerebral blood flow disorders [1,2,5].
• Astrocytes and interneurons can influence negative regulation of vasoconstriction via neurovascular coupling and BOLD fMRI responses [1,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes involved in negative regulation of vasoconstriction [3,4,7].
Description
Negative regulation of vasoconstriction (GO:0045906) is a biological process that counteracts the narrowing of blood vessels, thereby maintaining or restoring vascular diameter and tissue perfusion [1,7]. This process is essential for moment-to-moment control of blood flow in organs such as the brain, kidney, and peripheral tissues, where excessive vasoconstriction can lead to ischemia or hypertension [1,4,7]. Understanding how vasoconstriction is negatively regulated provides mechanistic insight into cardiovascular homeostasis and disease [2,5,8]. At the cellular level, negative regulation of vasoconstriction involves coordinated actions of ion channels, G-protein-coupled receptors, and cytoskeletal proteins in vascular smooth muscle cells and endothelial cells [3,4,7,8]. For example, activation of potassium channels hyperpolarizes smooth muscle membranes and reduces calcium influx, thereby opposing vasoconstriction [3,8]. Similarly, calcium-sensing receptor signaling by vasoconstriction-inhibiting factor can directly inhibit vascular calcification and modulate tone. These mechanisms are conserved across species and are studied using rodent models, isolated vessel preparations, and genetic tools [3,4,7]. For researchers, GO:0045906 offers a framework to annotate genes and pathways that suppress vasoconstriction, linking molecular events to physiological outcomes such as cerebral blood flow regulation and orthostatic tolerance [1,5,6]. This article synthesizes authoritative QuickGO definitions with real PubMed literature to outline the mechanisms, key genes, disease relevance, and experimental strategies for studying negative regulation of vasoconstriction.
negative regulation of vasoconstriction At A Glance
| GO ID | GO:0045906 |
|---|---|
| GO term | negative regulation of vasoconstriction |
| Ontology | biological_process |
| Synonym | down regulation of vasoconstriction, down-regulation of vasoconstriction, downregulation of vasoconstriction, inhibition of vasoconstriction |
| Major function | Opposes vasoconstriction to maintain or restore blood vessel diameter and tissue perfusion |
| Related processes | Regulation of blood pressure, vascular smooth muscle contraction, neurovascular coupling |
| Key cell types | Vascular smooth muscle cells, endothelial cells, astrocytes, interneurons |
| Representative molecules | Kv7 channels, calcium-sensing receptor, caldesmon, potassium channels |
| Disease relevance | Neurogenic orthostatic hypotension, vascular calcification, cerebral blood flow disorders |
What Is GO:0045906?
According to the Gene Ontology, negative regulation of vasoconstriction (GO:0045906) is any process that stops, prevents, or reduces the frequency, rate, or extent of vasoconstriction. In other words, it encompasses biological mechanisms that actively oppose the narrowing of blood vessels, whether by inhibiting contractile signaling in vascular smooth muscle, promoting vasodilation, or modulating neural and endothelial inputs that control vascular tone [1,7].
Why Is negative regulation of vasoconstriction Important in Cell Biology?
Negative regulation of vasoconstriction is critical for cardiovascular health because it prevents excessive vascular narrowing that can impair tissue oxygen delivery and contribute to ischemia, hypertension, and organ damage [1,2,5,7]. This process also underlies neurovascular coupling, where neuronal activity triggers local blood flow increases that are detected by functional imaging such as BOLD fMRI [1,6]. Dysregulation of negative regulation of vasoconstriction is implicated in neurogenic orthostatic hypotension, vascular calcification, and renal vascular disorders, making it a target for therapeutic intervention and a focus for genetic studies [2,4,5].
• Maintains cerebral blood flow by counteracting vasoconstriction in response to neural activity.
• Prevents excessive vascular calcification through calcimimetic signaling.
• Regulates renal preglomerular vascular tone via caldesmon and potassium channels.
• Influences BOLD fMRI signals through interneuron and astrocyte activity.
• Contributes to blood pressure homeostasis and orthostatic tolerance [5,7].
• Provides mechanistic targets for treating neurogenic orthostatic hypotension.
• Involves potassium channels that act as negative feedback regulators of vasocontraction [3,8].
• Serves as a model for studying ion channel regulation of myogenic tone.
• Links neurovascular unit function to vascular smooth muscle contractility [1,6].
• Offers CRISPR-editable targets for causal gene validation in cardiovascular research [3,4,7].
What Happens During negative regulation of vasoconstriction?
Initiation by vasodilatory or inhibitory signals
In simple terms: The process starts when signals that oppose vessel narrowing are received by vascular cells.
Negative regulation of vasoconstriction can be initiated by endothelial factors, neural inputs, or circulating molecules that reduce intracellular calcium or activate hyperpolarizing currents in vascular smooth muscle cells [1,7]. For instance, astrocytic calcium signaling can trigger vasodilation in cerebral arterioles, counteracting vasoconstriction. Similarly, vasoconstriction-inhibiting factor acts as a calcimimetic on the calcium-sensing receptor to inhibit vascular calcification and modulate tone.
Ion channel-mediated hyperpolarization
In simple terms: Potassium channels open to make the muscle cell less excitable, which relaxes the vessel.
Activation of potassium channels, particularly Kv7 channels, produces membrane hyperpolarization that reduces voltage-gated calcium channel activity and lowers intracellular calcium, thereby opposing vasoconstriction [3,8]. In 10- to 15-day-old rats, Kv7 channels play a dominant role in negative feedback regulation of vasocontraction. Other potassium channels also contribute to the regulation of myogenic tone in peripheral arterioles.
Cytoskeletal and contractile modulation
In simple terms: Proteins that control the cell's internal skeleton can reduce the force of contraction.
Caldesmon, an actin-binding protein, regulates vascular tone in preglomerular renal vasculature by modulating smooth muscle contractility. Changes in caldesmon activity can decrease the sensitivity of the contractile apparatus to calcium, thereby contributing to negative regulation of vasoconstriction.
Neurovascular coupling and interneuron involvement
In simple terms: Brain cells communicate with blood vessels to adjust blood flow according to neural activity.
Astrocytes and interneurons participate in neurovascular coupling, where neuronal activity leads to local vasodilation that opposes vasoconstriction [1,6]. Functional deficiency of interneurons can alter negative BOLD fMRI responses, indicating that inhibitory neurons influence the balance between vasoconstriction and its negative regulation.
Integration with systemic blood pressure control
In simple terms: The whole body adjusts blood pressure by balancing vessel narrowing and widening.
Negative regulation of vasoconstriction is integrated with autonomic and hormonal systems to maintain blood pressure, especially during posture changes [5,7]. In neurogenic orthostatic hypotension, impaired negative regulation of vasoconstriction contributes to symptoms such as dizziness and syncope.
Key Genes Involved in GO:0045906 negative regulation of vasoconstriction
The following genes and proteins are experimentally implicated in negative regulation of vasoconstriction, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNQ1 | Forms Kv7 potassium channels that hyperpolarize smooth muscle | Studied for negative feedback regulation of vasocontraction |
| KCNQ2 | Contributes to Kv7 channel complexes in vascular tissue | Target for modulating vascular tone |
| KCNQ3 | Part of Kv7 channels in smooth muscle | Involved in negative regulation of vasoconstriction |
| KCNQ4 | Kv7 channel subunit in vascular smooth muscle | Potential modulator of myogenic tone [3,7] |
| KCNQ5 | Kv7 channel subunit with roles in vascular relaxation | Studied in peripheral arterioles [3,7] |
| CASR | Calcium-sensing receptor mediating calcimimetic effects | Target of vasoconstriction-inhibiting factor |
| CALD1 | Caldesmon regulates actin-myosin interaction | Regulates preglomerular renal vascular tone |
| KCNMA1 | Large-conductance calcium-activated potassium channel | Modulates vascular smooth muscle tone [7,8] |
| KCNJ8 | Kir6.1 subunit of KATP channels | Involved in metabolic regulation of vascular tone |
| ABCC9 | SUR2 subunit of KATP channels | Regulates potassium conductance in smooth muscle |
| KCNJ2 | Kir2.1 inward rectifier potassium channel | Contributes to membrane potential in arterioles |
| KCNJ5 | G-protein-gated potassium channel | Modulates vascular excitability |
| GJA1 | Connexin 43 gap junction protein | Facilitates endothelial-smooth muscle communication |
| NOS3 | Endothelial nitric oxide synthase | Produces nitric oxide that opposes vasoconstriction |
| GUCY1A1 | Soluble guanylate cyclase subunit | Mediates nitric oxide signaling in smooth muscle |
| PRKG1 | cGMP-dependent protein kinase | Phosphorylates targets to reduce calcium sensitivity |
| ADORA2A | Adenosine receptor A2A | Mediates adenosine-induced vasodilation |
| KCNK3 | TWIK-related acid-sensitive potassium channel | Regulates resting membrane potential in vascular cells |
How Is negative regulation of vasoconstriction Regulated?
Negative regulation of vasoconstriction is itself regulated by multiple signaling pathways. Potassium channels, including Kv7 and KATP channels, act as negative feedback regulators of vasocontraction by sensing membrane potential and metabolic state [3,7,8]. Calcium-sensing receptor signaling by vasoconstriction-inhibiting factor provides an endocrine-like control of vascular calcification and tone. Neurovascular coupling mechanisms involving astrocytes and interneurons adjust local blood flow based on neuronal activity, thereby dynamically regulating the process [1,6]. Additionally, caldesmon phosphorylation and actin cytoskeleton dynamics modulate the contractile machinery to fine-tune vascular tone.
negative regulation of vasoconstriction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CASR | Vascular calcification | Knockout or point-mutation in vascular smooth muscle cells |
| CALD1 | Renal vascular tone disorders | Knockout in preglomerular arterioles |
| KCNQ1 | Neurogenic orthostatic hypotension | Overexpression in rodent models [3,5] |
| KCNQ5 | Cerebral blood flow disorders | Knock-in of human variant in mice [3,6] |
| NOS3 | Endothelial dysfunction | Endothelial-specific knockout |
Neurogenic orthostatic hypotension
Neurogenic orthostatic hypotension is characterized by a failure to adequately constrict blood vessels upon standing, and impaired negative regulation of vasoconstriction may contribute to symptom severity. Patients experience dizziness, lightheadedness, and syncope due to insufficient vascular compensation. Research into negative regulation of vasoconstriction could identify targets to improve orthostatic tolerance.
Vascular calcification
Vascular calcification involves pathological deposition of calcium in vessel walls, often associated with dysregulated vascular tone. Vasoconstriction-inhibiting factor acts as a calcimimetic on the calcium-sensing receptor, linking negative regulation of vasoconstriction to inhibition of calcification. This suggests that enhancing negative regulation of vasoconstriction may have therapeutic potential in calcific vascular disease.
Cerebral blood flow disorders
Proper negative regulation of vasoconstriction is essential for cerebral blood flow regulation, and its disruption is implicated in conditions such as stroke and vascular cognitive impairment. Astrocyte regulation of cerebral blood flow directly involves negative regulation of vasoconstriction mechanisms. Interneuron dysfunction can also alter neurovascular coupling and BOLD fMRI responses, highlighting the role of inhibitory neurons in this process.
Renal vascular disorders
Caldesmon regulates vascular tone in preglomerular renal vasculature, and its dysfunction may contribute to renal hemodynamic disorders. Negative regulation of vasoconstriction in the kidney is critical for maintaining glomerular filtration rate and preventing hypertension. Targeting caldesmon or associated pathways could offer new approaches for renal vascular diseases.
From negative regulation of vasoconstriction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does KCNQ1 mediate negative feedback of vasocontraction? | Knockout rat or mouse |
| Does CASR activation inhibit vascular calcification? | Point-mutation knock-in of CASR |
| Does caldesmon regulate renal vascular tone? | Knockout of CALD1 in vascular smooth muscle |
| Does interneuron activity affect BOLD fMRI via vasoconstriction? | Overexpression of interneuron-specific genes |
| Does astrocyte signaling regulate cerebral blood flow? | Knock-in of astrocyte-specific reporters |
| Does NOS3 overexpression improve orthostatic tolerance? | Overexpression in mouse endothelium |
How to Study the negative regulation of vasoconstriction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pressure myography | Arteriole diameter changes | Assessing vasoconstriction and its negative regulation [3,4] |
| Patch-clamp | Ion channel currents | Characterizing potassium channel function [3,7,8] |
| Calcium imaging | Intracellular calcium levels | Quantifying calcium handling in smooth muscle [1,4] |
| BOLD fMRI | Blood oxygenation changes | Neurovascular coupling studies [1,6] |
| Western blot | Protein expression and phosphorylation | Detecting caldesmon and channel subunits [4,7] |
| qPCR | mRNA expression levels | Validating gene expression changes [3,4] |
| Immunohistochemistry | Protein localization in tissues | Mapping channel distribution in vessels [1,4] |
| Wire myography | Isometric tension | Measuring contractile responses to agonists [7,8] |
Pressure myography
Pressure myography measures the diameter of isolated arterioles in response to intraluminal pressure and pharmacological agents, allowing direct assessment of negative regulation of vasoconstriction [3,4,7]. This method is used to study myogenic tone and the effects of potassium channel modulators [3,7].
Patch-clamp electrophysiology
Patch-clamp electrophysiology records ion channel currents in vascular smooth muscle cells, providing mechanistic insight into how potassium channels mediate hyperpolarization and negative regulation of vasoconstriction [3,7,8]. It is essential for characterizing Kv7 and KATP channel function [3,8].
Calcium imaging
Calcium imaging using fluorescent indicators measures intracellular calcium concentrations in vascular cells, a key determinant of contractile state [1,4]. This technique helps quantify how negative regulation of vasoconstriction reduces calcium influx or promotes calcium extrusion [1,4].
Functional MRI and neurovascular coupling
Functional MRI, including BOLD imaging, indirectly measures changes in blood flow and oxygenation that reflect negative regulation of vasoconstriction in the brain [1,6]. Interneuron dysfunction can alter BOLD responses, making this method useful for studying neurovascular mechanisms.
How CRISPR Can Be Used to Study GO:0045906 negative regulation of vasoconstriction
Knockout
CRISPR knockout of genes such as KCNQ1, CALD1, or CASR in vascular smooth muscle cells or rodent models can reveal their causal role in negative regulation of vasoconstriction [3,4,2]. For example, knockout of Kv7 channels would test their contribution to negative feedback regulation of vasocontraction.
Point Mutation
Point mutations can be introduced to mimic human variants or to disrupt specific functional domains, such as the calcium-sensing domain of CASR or phosphorylation sites in caldesmon [2,4]. These models help dissect signaling mechanisms without completely abolishing protein expression [2,4].
Knock-in
Knock-in of reporter genes or human disease-associated alleles allows tracking of gene expression and function in vivo [1,6]. For instance, knocking in a fluorescent reporter for NOS3 could visualize endothelial nitric oxide synthase dynamics during negative regulation of vasoconstriction.
Overexpression
Overexpression of candidate genes such as KCNQ5 or NOS3 in vascular cells can enhance negative regulation of vasoconstriction and test therapeutic potential [3,5,1]. Transgenic overexpression in mice is commonly used to study effects on blood pressure and orthostatic tolerance.
How EDITGENE Supports negative regulation of vasoconstriction Research
Researchers studying negative regulation of vasoconstriction-related genes often need to determine whether a candidate gene is causally involved in opposing vascular narrowing. CRISPR-based models provide a robust way to test gene function in relevant cell types and animal models, enabling precise dissection of molecular pathways [3,4,7].
Contact EDITGENE today to design your custom CRISPR model for negative regulation of vasoconstriction research.
Frequently Asked Questions About negative regulation of vasoconstriction
What is negative regulation of vasoconstriction?
Negative regulation of vasoconstriction (GO:0045906) is any process that stops, prevents, or reduces the frequency, rate, or extent of vasoconstriction, helping to maintain blood vessel diameter and tissue perfusion [1,7].
What genes are involved in negative regulation of vasoconstriction?
Key genes include KCNQ1-5 (Kv7 channels), CASR, CALD1, KCNMA1, and NOS3, which modulate vascular smooth muscle tone and endothelial function [2,3,4,7,8].
How does negative regulation of vasoconstriction work?
It works through ion channel hyperpolarization, calcium signaling reduction, cytoskeletal modulation, and neurovascular coupling to oppose vessel narrowing [1,3,4,7].
What diseases are linked to negative regulation of vasoconstriction?
Diseases include neurogenic orthostatic hypotension, vascular calcification, cerebral blood flow disorders, and renal vascular disorders [1,2,4,5,6].
Which potassium channels regulate vasoconstriction negatively?
Kv7 channels (KCNQ family) and KATP channels are major negative feedback regulators of vasocontraction [3,7,8].
What is the role of caldesmon in vascular tone?
Caldesmon regulates actin-myosin interaction in preglomerular renal vasculature, contributing to negative regulation of vasoconstriction.
How can I study negative regulation of vasoconstriction in the lab?
Methods include pressure myography, patch-clamp, calcium imaging, BOLD fMRI, and CRISPR-based genetic models [1,3,4,6,7].
What is vasoconstriction-inhibiting factor?
Vasoconstriction-inhibiting factor is an endogenous calcimimetic that acts on the calcium-sensing receptor to inhibit vascular calcification and modulate tone.
Do astrocytes regulate negative regulation of vasoconstriction?
Yes, astrocytes regulate cerebral blood flow and participate in neurovascular coupling, which involves negative regulation of vasoconstriction.
What CRISPR models are available for studying this process?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like KCNQ1, CASR, and CALD1 [2,3,4].
Conclusion
Negative regulation of vasoconstriction (GO:0045906) is a vital biological process that counteracts vascular narrowing through ion channels, signaling receptors, and cytoskeletal proteins [1,3,4,7]. Its dysregulation is linked to orthostatic hypotension, vascular calcification, and cerebral blood flow disorders, making it a compelling target for cardiovascular research [2,5,6]. CRISPR-based models offer powerful tools to dissect the causal roles of specific genes in this process [3,4,7].
References
- 1. Mishra A et al.. 2024. Astrocyte Regulation of Cerebral Blood Flow in Health and Disease.. Cold Spring Harb Perspect Biol 16(4) PMID: 38316553
- 2. de la Puente-Secades S et al.. 2025. Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor.. Cardiovasc Res 121(3):507-521 PMID: 40042167
- 3. Shvetsova AA et al.. 2019. Negative feedback regulation of vasocontraction by potassium channels in 10- to 15-day-old rats: Dominating role of K(v) 7 channels.. Acta Physiol (Oxf) 225(2):e13176 PMID: 30136434
- 4. Pryymachuk G et al.. 2026. Regulation of Vascular Tone of Preglomerular Renal Vasculature by Caldesmon.. J Am Heart Assoc 15(2):e046679 PMID: 41553092
- 5. Claassen DO et al.. 2018. Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers.. BMC Neurol 18(1):125 PMID: 30144800
- 6. Aksenov DP et al.. 2023. Functional Deficiency of Interneurons and Negative BOLD fMRI Response.. Cells 12(5) PMID: 36899947
- 7. Jackson WF. 2020. Ion channels and the regulation of myogenic tone in peripheral arterioles.. Curr Top Membr 85:19-58 PMID: 32402640
- 8. Jackson WF. 2018. K(V) channels and the regulation of vascular smooth muscle tone.. Microcirculation 25(1) PMID: 28985443
